Metolazone

Chemstrip 5 OB (Leukocytes, Protein, Glucose, Blood, Nitrite), CLIA Waived, 100/vial (12 ea/plt) (Minimum Expiry Lead is 90 days) (Item is Non-Returnable) (Continental US Only)

Synonym(s): (^+)1-(Isopropylamino)-3-[4-(^b-methoxyethyl)phenoxy]-2-propanol (+)-tartrate salt Formula: (C15H25NO3)2.C4H6O6 Formula weight: 684.82 Purity: 98+% CAS Number: 56392-17-7 Harmonized Tariff Code: 2922.19

Grade: Reagent, ACS CAS No.: 60-10-6

1,1-Dimethylbiguanide hydrochloride (metformin) is a strong base. It forms well defined salts and possessing excellent coordination capacity with transition metals, forming highly colored bidentate chelate complexes.

The GFS Chemicals ACS dithizone reagent is mainly used in research facilities and chemical laboratories to conduct wide range of experiments. It is available in sturdy bottle that endures heavy and rigorous usage.

CAS: 60-10-6 EC No: 200-454-1 MDL No: MFCD00003025 RTECS: LQ9450000 Crystalline Molecular Formula: C₁₃H₁₂N₄S MW: 256.33 Melting Point: 168&deg (decomposes)

Larotinib mesylate hydrate is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC 50 of 0.6 nMIn VivoAfter daily administration of Larotinib mesylate hydrate, the no observed adverse

Larotinib mesylate hydrate is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC 50 of 0.6 nMIn VivoAfter daily administration of Larotinib mesylate hydrate, the no observed adverse

Larotinib mesylate hydrate is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC 50 of 0.6 nMIn VivoAfter daily administration of Larotinib mesylate hydrate, the no observed adverse

Ranolazine Dihydrochloride is a novel metabolic modulator and membrane stabilizer that is an antianginal and antiischaemic agent. This compound shifts myocardial energy metabolism away from free fatty acids and toward glucose as the substrate for

Ranolazine Dihydrochloride is a novel metabolic modulator and membrane stabilizer that is an antianginal and antiischaemic agent. This compound shifts myocardial energy metabolism away from free fatty acids and toward glucose as the substrate for

Metipranolol hydrochloride is a non-selective β adrenergic receptor blocking agent.In VitroMetipranolol is used systemically for the treatment of arterial hypertension and topically for the management of glaucoma. MCE has not independently confirmed